Currently out of the existing stock ratings of John Boris, 25 are a BUY (86.21%), 4 are a HOLD (13.79%).

John Boris

Work Performance Price Targets & Ratings Chart

Analyst John Boris, carries an average stock price target met ratio of 64.44% that have a potential upside of 42.96% achieved within 672 days. Previously, John Boris worked at ROTH.

John Boris’s has documented 58 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, Common Stock at 10-Jul-2019.

Wall Street Analyst John Boris

Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK) at 12/18/2018. The price target of $13 was fulfilled within 27 days with a profit of $2.91 (18.29%) receiving and performance score of 6.77.

Average potential price target upside

of $60.39 (85.01%) on ABBV (ABBVIE).
of $31.64 (45.12%) on LLY (ELI LILLY AND COMPANY).
of $20.64 (45.93%) on MRK (MERCK MPANY).

AMRX Amneal Pharmaceuticals, Common Stock MRK Merck mpany JAZZ Jazz Pharmaceuticals PLC LLY Eli Lilly and Company ABBV AbbVie AGN Allergan plc AMRN Amarin PLC PFE Pfizer SUPN Supernus Pharmaceuticals AVDL Avadel Pharmaceuticals PLC

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Chris Schott (JPMORGAN)